Addition of Raltegravir to Established Antiretroviral Suppressive Therapy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Rafael Campo, University of Miami
ClinicalTrials.gov Identifier:
NCT01245101
First received: November 19, 2010
Last updated: December 8, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)